Science Explorer Interactive view Map
Company · Modena · Italy

Tydock Pharma (Italy)

tydockpharma.comROR OpenAlex
Research works
16
▼ 18% vs 2013–17
Citations
283
17.3 per fractional work
Top-10% rate
36.4%
record average 16.5%
Open access
60%
world 28%

Not ranked overall: Tydock Pharma (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.68× its world share, 0 worksBiochemistry, Geneti…Computer Science: 0.10× its world share, 0 worksComputer ScienceEnvironmental Science: 0.55× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.44× its world share, 0 worksHealth ProfessionsMedicine: 1.92× its world share, 2 worksMedicineBusiness, Management and Accounting: 3.37× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 17.44× its world share, 2 worksEconomics, Econometr…Psychology: 0.38× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 17.4×. Every wedge is a field page.

Which research topics does Tydock Pharma (Italy) publish most on?

By volume in 2022–2025: Pharmaceutical Economics and Policy, Health Systems, Economic Evaluations, Quality of Life, Diet and metabolism studies and Bariatric Surgery and Outcomes.

Pharmaceutical Economics…1Pharmaceutical Economics and Policy: 1 fractional worksHealth Systems, Economic…0Health Systems, Economic Evaluations, Quality of Life: 0 fractional worksDiet and metabolism stud…0Diet and metabolism studies: 0 fractional worksBariatric Surgery and Outcomes: 0 fractional worksIntellectual Property and Patents: 0 fractional worksDigestive system and rel…0Digestive system and related health: 0 fractional worksLong-Term Effects of COVID-19: 0 fractional worksSARS-CoV-2 and COVID-19 Research: 0 fractional worksCOVID-19 Clinical Research Studies: 0 fractional worksEconomic and Financial Impacts of Cancer: 0 fractional works
Economics and EconometricsPhysiologySurgeryManagement of Technology and Innovation3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  3. 3 Diet and metabolism studies Physiology 0 works
  4. 4 Bariatric Surgery and Outcomes Surgery 0 works
  5. 5 Intellectual Property and Patents Management of Technology and Innovation 0 works
  6. 6 Digestive system and related health Genetics 0 works
  7. 7 Long-Term Effects of COVID-19 Neurology 0 works
  8. 8 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  9. 9 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  10. 10 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.7%not open40.3%

World: 28% of research is openly available.

with international co-authors34.4%domestic only65.6%

World: 19% is written across borders.

How has Tydock Pharma (Italy)'s research output changed?

Output in 2018–2022 was 18% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Modena

All research institutions in Modena

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.